While Royal Philips Electronics recorded a net income of 200 million ($270.8 million U.S.) for the 2010 first quarter compared with a net loss of 59 million ($79.5 million U.S.) in the 2009 first quarter, Philips Healthcare also saw a 20 percent growth in equipment order intake.

Spacelabs Healthcare has released Ultraview DM3, which provides caregivers with a dual-mode technology for measuring vital signs (SpO2, pulse rate, non-invasive blood pressure, respiration and temperature) on adult and pediatric patients.

OrbusNeich Medical, a developer and marketer of medical devices for the treatment of cardiovascular diseases, was granted U.S. Patent No. 7,682,384 B2, entitled Stent with Helical Elements, relating to an expandable stent comprised of a plurality of helical segments.

After more than one month of playing the waiting game, Boston Scientific has received the green light from the FDA to continue shipments of its Cognis cardiac resynchronization therapy defibrillators (CRT-D) and Teligen implantable cardioverter-defibrillators (ICDs).

Congress passed the Continuing Extension Act of 2010 earlier this week. As widely reported, the bill extends unemployment insurance and postpones the 21 percent cut in physician reimbursement under Medicare until June 1. Another section of the bill has received less coverage, but is just as significant for a multitude of practitionersthe EHR Clarification language for qualification for clinic-based physicians.

Americans who have access to their health information through personal health records (PHRs) report that they know more about their health, ask more questions and take better care of themselves than when their medical information was less accessible to them in paper records, according to a survey from the California HealthCare Foundation (CHCF).

biospace med has raised $18 million to expand the market for the EOS low-dose 2D/3D musculoskeletal imaging system in the U.S. and Europe.

Verizon Wireless, BL Healthcare and a number of customers and third-party providers will jointly trial products for the delivery of remote healthcare applications and services to patients.